Published in Proc Natl Acad Sci U S A on January 10, 2007
Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov (2010) 7.48
Targeting of drugs and nanoparticles to tumors. J Cell Biol (2010) 4.07
Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell (2009) 4.02
Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev (2008) 3.34
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci U S A (2011) 2.37
Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics (2012) 2.35
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomedicine (2008) 2.20
Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. Small (2009) 2.16
Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma. Cancer Res (2008) 2.13
Targeted hyperthermia using metal nanoparticles. Adv Drug Deliv Rev (2009) 2.12
Refilling drug delivery depots through the blood. Proc Natl Acad Sci U S A (2014) 2.10
Nanoparticle biointerfacing by platelet membrane cloaking. Nature (2015) 2.09
Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging. Adv Mater (2008) 2.01
In vivo tumor cell targeting with "click" nanoparticles. Bioconjug Chem (2008) 2.01
Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. Small (2009) 1.93
Targeting of albumin-embedded paclitaxel nanoparticles to tumors. Nanomedicine (2008) 1.90
Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev (2010) 1.88
Receptor-targeted nanoparticles for in vivo imaging of breast cancer. Clin Cancer Res (2009) 1.86
Targeting atherosclerosis by using modular, multifunctional micelles. Proc Natl Acad Sci U S A (2009) 1.76
Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. J Control Release (2010) 1.64
Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol (2011) 1.60
Nanotechnology, nanotoxicology, and neuroscience. Prog Neurobiol (2008) 1.59
Peptides as targeting elements and tissue penetration devices for nanoparticles. Adv Mater (2012) 1.41
Templated spherical high density lipoprotein nanoparticles. J Am Chem Soc (2009) 1.34
Nanoparticle-induced vascular blockade in human prostate cancer. Blood (2010) 1.30
Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials (2010) 1.29
Enabling individualized therapy through nanotechnology. Pharmacol Res (2010) 1.28
Behavior of endogenous tumor-associated macrophages assessed in vivo using a functionalized nanoparticle. Neoplasia (2009) 1.28
Biomimetic delivery with micro- and nanoparticles. Adv Mater (2012) 1.25
Optical imaging-guided cancer therapy with fluorescent nanoparticles. J R Soc Interface (2009) 1.22
Inorganic nanoparticle-based contrast agents for molecular imaging. Trends Mol Med (2010) 1.21
Magnetic particle imaging (MPI) for NMR and MRI researchers. J Magn Reson (2012) 1.19
Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. Biomaterials (2009) 1.19
Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging. J Biomed Nanotechnol (2008) 1.17
Retracted Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential. Biochem Pharmacol (2010) 1.16
In vivo assembly of nanoparticle components to improve targeted cancer imaging. Proc Natl Acad Sci U S A (2010) 1.15
Comparison of electron spin resonance spectroscopy and inductively-coupled plasma optical emission spectroscopy for biodistribution analysis of iron-oxide nanoparticles. Mol Pharm (2010) 1.12
Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis. ACS Nano (2013) 1.12
M13 phage-functionalized single-walled carbon nanotubes as nanoprobes for second near-infrared window fluorescence imaging of targeted tumors. Nano Lett (2012) 1.11
Effect of ligand density, receptor density, and nanoparticle size on cell targeting. Nanomedicine (2012) 1.10
Ovarian normal and tumor-associated fibroblasts retain in vivo stromal characteristics in a 3-D matrix-dependent manner. Gynecol Oncol (2008) 1.07
Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem Pharmacol (2010) 1.05
Dynamic imaging of arginine-rich heart-targeted vehicles in a mouse model. Biomaterials (2008) 1.03
Multifunctional magnetic nanoparticles for targeted delivery. Nanomedicine (2009) 1.03
MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent. Nat Commun (2015) 1.01
Optimization of iron oxide nanoparticle detection using ultrashort echo time pulse sequences: comparison of T1, T2*, and synergistic T1- T2* contrast mechanisms. Magn Reson Med (2011) 1.01
Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans. PLoS One (2012) 1.00
Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma. Biomaterials (2013) 1.00
Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery. J Transl Med (2012) 0.96
Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI. Biomaterials (2013) 0.96
Silicon nanoparticles as hyperpolarized magnetic resonance imaging agents. ACS Nano (2009) 0.95
Enzyme-directed assembly of a nanoparticle probe in tumor tissue. Adv Mater (2013) 0.95
Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A (2011) 0.95
Enzyme-directed assembly of nanoparticles in tumors monitored by in vivo whole animal imaging and ex vivo super-resolution fluorescence imaging. J Am Chem Soc (2013) 0.93
Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer. Bioconjug Chem (2012) 0.93
Self-titrating anticoagulant nanocomplexes that restore homeostatic regulation of the coagulation cascade. ACS Nano (2014) 0.93
Fluorescent tumour imaging of type I IGF receptor in vivo: comparison of antibody-conjugated quantum dots and small-molecule fluorophore. Br J Cancer (2009) 0.93
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chem Soc Rev (2015) 0.92
Therapeutic nanomedicine for brain cancer. Ther Deliv (2013) 0.92
Synthesis and characterization of CREKA-conjugated iron oxide nanoparticles for hyperthermia applications. Acta Biomater (2014) 0.91
Targeted nanoagents for the detection of cancers. Mol Oncol (2010) 0.91
Peptide-mediated cancer targeting of nanoconjugates. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 0.89
Targeting vasculature in urologic tumors: mechanistic and therapeutic significance. J Cell Biochem (2008) 0.89
Shaping bio-inspired nanotechnologies to target thrombosis for dual optical-magnetic resonance imaging. J Mater Chem B Mater Biol Med (2015) 0.89
Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach. Biochemistry (2011) 0.87
Enzyme immobilization: an update. J Chem Biol (2013) 0.86
Bioresponsive nanosensors in medical imaging. J R Soc Interface (2009) 0.85
The energy landscape of a selective tumor-homing pentapeptide. J Phys Chem B (2008) 0.85
Intraperitoneal injection of magnetic Fe₃O₄-nanoparticle induces hepatic and renal tissue injury via oxidative stress in mice. Int J Nanomedicine (2012) 0.84
In silico molecular engineering for a targeted replacement in a tumor-homing peptide. J Phys Chem B (2009) 0.83
Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review. Interface Focus (2012) 0.82
Peptide targeted high-resolution molecular imaging of prostate cancer with MRI. Am J Nucl Med Mol Imaging (2014) 0.82
Application of Collagen-Model Triple-Helical Peptide-Amphiphiles for CD44-Targeted Drug Delivery Systems. J Drug Deliv (2012) 0.82
Fc-DIRECTED ANTIBODY CONJUGATION OF MAGNETIC NANOPARTICLES FOR ENHANCED MOLECULAR TARGETING. J Innov Opt Health Sci (2009) 0.81
Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo. J Control Release (2009) 0.81
Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications. Hum Vaccin Immunother (2012) 0.81
Nanocarrier-mediated targeting of tumor and tumor vascular cells improves uptake and penetration of drugs into neuroblastoma. Front Oncol (2013) 0.80
Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging. J Biomed Nanotechnol (2015) 0.80
Nanoparticle-mediated drug delivery for treating melanoma. Nanomedicine (Lond) (2015) 0.79
Enhanced magnetic resonance contrast of Fe₃O₄ nanoparticles trapped in a porous silicon nanoparticle host. Adv Mater (2011) 0.79
Non-viral nucleic acid containing nanoparticles as cancer therapeutics. Expert Opin Drug Deliv (2016) 0.79
Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor. Int J Nanomedicine (2015) 0.78
Phenylboronic Acid-Mediated Tumor Targeting of Chitosan Nanoparticles. Theranostics (2016) 0.78
The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo. Int J Nanomedicine (2015) 0.78
Somatostatin receptor type 2-based reporter expression after plasmid-based in vivo gene delivery to non-small cell lung cancer. Mol Imaging (2013) 0.78
Two-Step Delivery: Exploiting the Partition Coefficient Concept to Increase Intratumoral Paclitaxel Concentrations In vivo Using Responsive Nanoparticles. Sci Rep (2016) 0.78
Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect. Int J Nanomedicine (2014) 0.78
Targeted Nanotherapies for the Treatment of Surgical Diseases. Ann Surg (2016) 0.78
Theranostic tumor homing nanocarriers for the treatment of lung cancer. Nanomedicine (2013) 0.77
Engineering strategy to improve peptide analogs: from structure-based computational design to tumor homing. J Comput Aided Mol Des (2012) 0.77
Smart nanosystems: Bio-inspired technologies that interact with the host environment. Proc Natl Acad Sci U S A (2015) 0.76
A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries. Nat Commun (2016) 0.76
Magnetite Nanoparticles Induce Genotoxicity in the Lungs of Mice via Inflammatory Response. Nanomaterials (Basel) (2014) 0.75
The potential of polymeric micelles in the context of glioblastoma therapy. Front Pharmacol (2013) 0.75
A Hybrid Peptide PTS that Facilitates Transmembrane Delivery and Its Application for the Rapid In vivo Imaging via Near-Infrared Fluorescence Imaging. Front Pharmacol (2016) 0.75
Conformational profile of a proline-arginine hybrid. J Chem Inf Model (2010) 0.75
The effects of synthesis method on the physical and chemical properties of dextran coated iron oxide nanoparticles. Mater Chem Phys (2015) 0.75
Specific detection of CD133-positive tumor cells with iron oxide nanoparticles labeling using noninvasive molecular magnetic resonance imaging. Int J Nanomedicine (2015) 0.75
Nanotechnology: Platelet mimicry. Nature (2015) 0.75
Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods (1994) 13.53
Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev (2001) 10.02
Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett (2006) 5.63
Nanocrystal targeting in vivo. Proc Natl Acad Sci U S A (2002) 5.35
Organ targeting in vivo using phage display peptide libraries. Nature (1996) 5.20
Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res (2006) 4.99
Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol (1989) 3.59
Specialization of tumour vasculature. Nat Rev Cancer (2002) 3.30
Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev (1995) 3.27
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature (2004) 3.24
Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res (1990) 3.18
Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials (2004) 2.80
A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat Med (2002) 2.77
Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging (1995) 2.67
Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science (1997) 2.59
Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol (2005) 2.56
Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy. Clin Cancer Res (2005) 2.23
Regulation of extravascular coagulation by microvascular permeability. Science (1985) 2.11
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cell (2003) 2.07
Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci U S A (1999) 1.96
Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. Proc Natl Acad Sci U S A (2004) 1.82
Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages. J Magn Reson Imaging (1998) 1.77
Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds. Proc Natl Acad Sci U S A (2006) 1.68
Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging (1995) 1.38
The MET oncogene drives a genetic programme linking cancer to haemostasis. Nature (2005) 1.37
Two-dimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticles. Biomed Microdevices (2004) 1.29
Transgenic mouse models of human breast cancer. Oncogene (2000) 1.27
Ultrafine particles exert prothrombotic but not inflammatory effects on the hepatic microcirculation in healthy mice in vivo. Circulation (2004) 1.22
The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes. Biochim Biophys Acta (1981) 1.10
Effect of polymeric nanoparticle administration on the clearance activity of the mononuclear phagocyte system in mice. J Biomed Mater Res (1996) 0.94
A selective tumor microvasculature thrombogen that targets a novel receptor complex in the tumor angiogenic microenvironment. Cancer Res (2005) 0.93
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell (2002) 6.76
Dissecting p53 tumor suppressor functions in vivo. Cancer Cell (2002) 6.24
Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science (2010) 6.01
Nanocrystal targeting in vivo. Proc Natl Acad Sci U S A (2002) 5.35
Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater (2009) 4.77
Gene expression profiling predicts clinical outcome of prostate cancer. J Clin Invest (2004) 4.59
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature (2011) 4.57
Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial. Lancet (2006) 4.22
Targeting of drugs and nanoparticles to tumors. J Cell Biol (2010) 4.07
Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell (2009) 4.02
Nanoparticles that communicate in vivo to amplify tumour targeting. Nat Mater (2011) 3.83
Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res (2009) 3.77
Physical limits of cell migration: control by ECM space and nuclear deformation and tuning by proteolysis and traction force. J Cell Biol (2013) 3.77
Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest (2010) 3.74
MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One (2009) 3.66
Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci U S A (2011) 3.45
Porous silicon in drug delivery devices and materials. Adv Drug Deliv Rev (2008) 3.43
Development of real-time subcellular dynamic multicolor imaging of cancer-cell trafficking in live mice with a variable-magnification whole-mouse imaging system. Cancer Res (2006) 3.42
Biomolecular screening with encoded porous-silicon photonic crystals. Nat Mater (2002) 3.13
Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell (2004) 3.09
Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell (2013) 3.08
Nestin expression in hair follicle sheath progenitor cells. Proc Natl Acad Sci U S A (2003) 3.07
Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. Cancer Res (2009) 2.80
Multipotent nestin-positive, keratin-negative hair-follicle bulge stem cells can form neurons. Proc Natl Acad Sci U S A (2005) 2.78
A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat Med (2002) 2.77
Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci U S A (2005) 2.76
Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J Cell Biol (2003) 2.68
Subcellular imaging in the live mouse. Nat Protoc (2006) 2.63
Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. Cancer Cell (2003) 2.56
Biosensing using porous silicon double-layer interferometers: reflective interferometric Fourier transform spectroscopy. J Am Chem Soc (2005) 2.56
Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res (2006) 2.51
Whole-body imaging with fluorescent proteins. Nat Protoc (2006) 2.51
In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation. Proc Natl Acad Sci U S A (2009) 2.46
Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci U S A (2007) 2.46
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci U S A (2009) 2.41
Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer. J Gastrointest Surg (2008) 2.41
Multipotent hair follicle stem cells promote repair of spinal cord injury and recovery of walking function. Cell Cycle (2008) 2.39
Color-coded fluorescence imaging of tumor-host interactions. Nat Protoc (2006) 2.38
Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs. J Med Chem (2008) 2.35
A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo. Proc Natl Acad Sci U S A (2002) 2.35
Targeted quantum dot conjugates for siRNA delivery. Bioconjug Chem (2007) 2.31
Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium. Cell Cycle (2009) 2.28
Imaging of primary and metastatic pancreatic cancer using a fluorophore-conjugated anti-CA19-9 antibody for surgical navigation. World J Surg (2008) 2.27
Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. J Vasc Surg (2008) 2.24
Fluorescence-guided surgery allows for more complete resection of pancreatic cancer, resulting in longer disease-free survival compared with standard surgery in orthotopic mouse models. J Am Coll Surg (2012) 2.24
Implanted hair follicle stem cells form Schwann cells that support repair of severed peripheral nerves. Proc Natl Acad Sci U S A (2005) 2.22
Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. Small (2009) 2.16
Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma. Cancer Res (2008) 2.13
Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res (2002) 2.11
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cell (2003) 2.07
Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation. Mol Cell Biol (2010) 2.05
Targeting the prostate for destruction through a vascular address. Proc Natl Acad Sci U S A (2002) 2.01
Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging. Adv Mater (2008) 2.01
In vivo tumor cell targeting with "click" nanoparticles. Bioconjug Chem (2008) 2.01
Nascent blood vessels in the skin arise from nestin-expressing hair-follicle cells. Proc Natl Acad Sci U S A (2004) 2.00
Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs. Mol Pharmacol (2010) 1.99
Dual-color fluorescence imaging distinguishes tumor cells from induced host angiogenic vessels and stromal cells. Proc Natl Acad Sci U S A (2003) 1.98
Delivery of nanogram payloads using magnetic porous silicon microcarriers. Lab Chip (2006) 1.93
Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci U S A (2003) 1.91
Targeting of albumin-embedded paclitaxel nanoparticles to tumors. Nanomedicine (2008) 1.90
Cellular dynamics visualized in live cells in vitro and in vivo by differential dual-color nuclear-cytoplasmic fluorescent-protein expression. Cancer Res (2004) 1.90
Manipulation of liquid droplets using amphiphilic, magnetic one-dimensional photonic crystal chaperones. Nat Mater (2004) 1.89
Infrared multiphoton microscopy: subcellular-resolved deep tissue imaging. Curr Opin Biotechnol (2009) 1.86
Cooperative nanomaterial system to sensitize, target, and treat tumors. Proc Natl Acad Sci U S A (2009) 1.82
Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. Proc Natl Acad Sci U S A (2004) 1.82
A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. J Surg Res (2003) 1.82
Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice. Anticancer Res (2009) 1.81
Engineering the chemistry and nanostructure of porous silicon Fabry-Pérot films for loading and release of a steroid. Langmuir (2004) 1.81
SERS-Coded Gold Nanorods as a Multifunctional Platform for Densely Multiplexed Near-Infrared Imaging and Photothermal Heating. Adv Mater (2009) 1.79
Tumor-selective, adenoviral-mediated GFP genetic labeling of human cancer in the live mouse reports future recurrence after resection. Cell Cycle (2011) 1.76
Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer. J Surg Res (2009) 1.76
In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases. Cancer Res (2006) 1.76
Targeting atherosclerosis by using modular, multifunctional micelles. Proc Natl Acad Sci U S A (2009) 1.76